Knockdown of circ_0008344 contributes to radiosensitization in glioma via miR-433-3p/RNF2 axis

Liang DI1, Xiaofei Zhao, Jing Ding

  • 1General Surgery Department, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.

Journal of Biosciences
|August 23, 2021
PubMed

Insights

Knockdown of circ_0008344 enhances glioma radiosensitivity by sponging miR-433-3p and down-regulating RNF2. This circular RNA is a potential biomarker and therapeutic target for glioma radiotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are key regulators in cancer development and treatment resistance.
  • Glioma radiosensitivity is a critical factor in treatment outcomes.
  • Understanding the role of specific circRNAs in glioma radiosensitivity is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the function of circ_0008344 in regulating radiosensitivity in glioma.
  • To elucidate the underlying molecular mechanism involving microRNA-433-3p (miR-433-3p) and Ring finger protein 2 (RNF2).

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) for circRNA and miRNA expression analysis.
  • Cell viability and apoptosis assays (colony formation, flow cytometry) to assess radiosensitivity.
  • Western blot for protein level determination.
  • Dual-luciferase reporter assay for target interaction validation.
  • In vivo xenograft models in mice to evaluate therapeutic efficacy.

Main Results:

  • circ_0008344 expression was significantly elevated in radioresistant glioma tissues.
  • Down-regulation of circ_0008344 increased glioma cell sensitivity to radiation.
  • circ_0008344 acts as a sponge for miR-433-3p, and RNF2 is a downstream target regulated by this axis.
  • Knockdown of circ_0008344 enhanced radiosensitivity by down-regulating RNF2 via miR-433-3p, an effect reversed by RNF2 overexpression.
  • In vivo studies confirmed that circ_0008344 knockdown inhibited tumor growth and improved radiosensitivity.

Conclusions:

  • circ_0008344 promotes radioresistance in glioma by sponging miR-433-3p and consequently up-regulating RNF2.
  • Down-regulation of circ_0008344 enhances glioma radiosensitivity through the miR-433-3p/RNF2 pathway.
  • circ_0008344 represents a promising diagnostic biomarker for radioresistance and a potential therapeutic target in glioma radiotherapy.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K